Core Viewpoint - Enhanced Games is going public through a Nasdaq listing and a direct-to-consumer business aimed at democratizing access to performance enhancement tools and protocols [1] Group 1: Financial Aspects - The public offering is expected to raise $200 million for Enhanced Games, following a $40 million equity deal that will convert into public shares once trading begins [2] - The company plans to launch consumer health products, including testosterone replacement medicines, in early 2026 [3] Group 2: Competition and Athlete Participation - The competition will feature athletes like Olympic sprinter Fred Kerley and swimmer Ben Proud, competing for $250,000 first prizes [1] - Athletes will not undergo traditional drug testing but will adhere to medical profiling for health assurance prior to the competition [2] Group 3: Leadership Changes - Maximilian Martin has been appointed as CEO, with founder Aron D'Souza stepping back from daily operations while remaining a shareholder [5] - Sid Banthiya has joined as chief finance officer, and Rick Adams has been appointed as chief sporting officer [5] Group 4: Vision and Strategy - The CEO emphasized the integration of scientific progress with elite athletic performance to create a new sports property that enhances athletes' lives and promotes long-term health benefits under clinical supervision [4]